<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H44C81D7ABEBE42BCB8576D4159951AF9" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>117 HR 8828 IH: FDA Ethics Act of 2022</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2022-09-14</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">117th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 8828</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20220914">September 14, 2022</action-date><action-desc><sponsor name-id="K000382">Ms. Kuster</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To address potential conflicts of interest among entities serving as Food and Drug Administration contractors, and for other purposes.</official-title></form><legis-body id="H72F9DAD170144751B3E9C7352C3DA464" style="OLC"><section id="H10FFEA3077FB4CBEA9B7E1284F635E5C" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>FDA Ethics Act of 2022</short-title></quote>.</text></section><section id="H4BD818455B5946928A6A7E0330751BB3"><enum>2.</enum><header>Requirements regarding ongoing reporting of contractor conflicts of interest</header><subsection id="H5FB8B16FA77B409A8705210CE87CC606"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">The Secretary of Health and Human Services shall require entities that contract with the Food and Drug Administration—</text><paragraph id="HA5C712EEB2E041C8A26E546D152953F8"><enum>(1)</enum><text display-inline="yes-display-inline">to disclose, on an ongoing basis during the term of the contract, any information related to potential and actual conflicts of interest, including conflicts of interest concerning the contractor’s personnel, consultants, and subcontractors; and</text></paragraph><paragraph id="HB0299F7E793741729B6CC0D20CC2E770"><enum>(2)</enum><text>during the term of the contract, to refrain from entering into consulting or other contractual arrangements with any person to perform work that may reasonably create a potential or actual conflict of interest, without receiving the written approval of the contracting officer before the execution of the contractual arrangement. </text></paragraph></subsection><subsection id="HCB3267BBDCFE4602A073B75DE6ACBC0C"><enum>(b)</enum><header>Regulations</header><text>Not later than 18 months after the date of enactment of this Act, the Secretary, in consultation with the Federal Acquisition Regulatory Council, shall issue regulations to carry out subsection (a).</text></subsection></section><section id="HC38AD8EC503E4E2CB61E7B6565A6C886"><enum>3.</enum><header>Requirements regarding waivers relating to organizational conflicts of interest</header><subsection id="H8A703CD6B5A04D1BA1A5C691AB2C041E"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">The Secretary of Health and Human Services (referred to in this section as the <quote>Secretary</quote>) shall, not later than 14 days after awarding a contract relating to the Food and Drug Administration, publish, on the website of the Food and Drug Administration, a notification of any waiver of any requirements regarding a potential or actual organizational conflict of interest granted to the contractor. Such notification shall be made publicly available in an easily accessible format, and shall include the name of the contract, the contractor receiving the waiver, the other contracts or clients that created the potential or actual organizational conflict of interest, and the efforts that the contractor plans to take to mitigate the potential or actual organizational conflict of interest. </text></subsection><subsection id="H157739E7D1FF46AF9141E78C5AF1159E"><enum>(b)</enum><header>Regulations</header><text>Not later than 18 months after the date of enactment of this Act, the Secretary, in consultation with the Federal Acquisition Regulatory Council, shall issue regulations to carry out subsection (a). </text></subsection></section><section id="HAA0E61078BA44942BD183E9442331666"><enum>4.</enum><header>Restrictions on consulting firms serving as FDA contractors</header><subsection id="H03E2C7E839994467A4245842D42CC38F"><enum>(a)</enum><header>Prohibition against certain contracts</header><paragraph id="H5249A40144044BA4A20FE66D155631A2"><enum>(1)</enum><header>In general</header><text display-inline="yes-display-inline">Subject to paragraph (2), the Secretary of Health and Human Services (referred to in this section as the <quote>Secretary</quote>) shall not award a contract relating to the duties of the Food and Drug Administration to any person providing consulting services (referred to in this section as a <quote>consulting firm</quote>) unless such contract provides that, during the restricted period described in paragraph (3), subject to paragraph (2), no individual employee or subcontractor of such consulting firm may provide services to both—</text><subparagraph id="H9DB1FDDF7D9746AD9821F70D7587DA3D"><enum>(A)</enum><text display-inline="yes-display-inline">the Food and Drug and Administration under the consulting firm’s contract; and</text></subparagraph><subparagraph id="HC10F34B8A98040CBA20EB2E765CF6E9E"><enum>(B)</enum><clause commented="no" display-inline="yes-display-inline" id="H0BCB4848B07D4B3DA41FC8C99F09BC2A"><enum>(i)</enum><text display-inline="yes-display-inline">a person engaged in the development or manufacturing of a device, drug, or biological product; or </text></clause><clause id="H3C74424E8ADC4956910FD2232AEAF925" indent="up1"><enum>(ii)</enum><text display-inline="yes-display-inline">any other private entity engaged in activities regulated by the Food and Drug Administration. </text></clause></subparagraph></paragraph><paragraph id="H3FC4337D3F314CB49106F430ECCAC227"><enum>(2)</enum><header>Exception</header><subparagraph id="HC0578DEE44A74378B9B3CB16731E1739"><enum>(A)</enum><header>In general</header><text>The Secretary may issue an exception to the requirement under paragraph (1) with respect to an employee or subcontractor of a consulting firm only if the Secretary or designee determines in writing that there is a compelling reason to award a contract with such consulting firm with such exception. The Secretary shall not delegate the authority to issue exceptions under this subparagraph below the level of head of a contracting activity. </text></subparagraph><subparagraph id="H005ED7F10E8144DEADEB15A42DF49B0F"><enum>(B)</enum><header>Reporting</header><text>Not later than 14 days after issuing an exception under subparagraph (A), the Secretary shall publish, on the website of the Food and Drug Administration, a notification of the exception. Such notification shall be made publicly available in an easily accessible format, and shall include—</text><clause id="H9900B3A5784A4BD7A292DA9F75925267"><enum>(i)</enum><text>the name of the contract;</text></clause><clause id="H1EA13B5DA79243CC95A6B2F0508D83BB"><enum>(ii)</enum><text>the consulting firm receiving the exception, and the employee or subcontractor to whom the exception applies; </text></clause><clause id="H2881FD3E60414BB0B02EA56AB37D87AE"><enum>(iii)</enum><text>the other contracts or clients that would, in the absence of the exception, cause the consulting firm to be in violation of paragraph (1); and </text></clause><clause id="H13746522E3C84893AEAF3AA3E7070B97"><enum>(iv)</enum><text>the efforts that the consulting firm plans to take to mitigate any potential or actual conflict of interest arising from the other work of its employees or subcontractors.</text></clause></subparagraph></paragraph><paragraph id="HA72085DF51CE4B2787398CB6E2B231DC"><enum>(3)</enum><header>Restricted period</header><subparagraph id="H5938F65090D84639AD9A964C764813BC"><enum>(A)</enum><header>In general</header><text>For purposes of paragraph (1), the restricted period is the period that—</text><clause id="HC4860AC4C93F4E1EA235A8D8B0BDDEC0"><enum>(i)</enum><text>begins when the applicable employee or subcontractor of the consulting firm first provides services under the consulting firm’s contract; and</text></clause><clause id="HA601A5EC792A4C4FB1AA82C3852A1384"><enum>(ii)</enum><text>ends not less than the applicable period specified in subparagraph (B) after the last date on which such employee or subcontractor provides services under the consulting firm’s contract. </text></clause></subparagraph><subparagraph id="H731E26853360481D89A0312A15FC1363"><enum>(B)</enum><header>Applicable period specified</header><text>For purposes of subparagraph (A)(ii), the applicable period specified in this subparagraph is—</text><clause id="HD3A36C0F774D450AA1E1B2F0FDE7C518"><enum>(i)</enum><text>30 days; or</text></clause><clause id="H9EA0DBB028E84774998E0987E2E5AAAD"><enum>(ii)</enum><text>such longer period of time as the Secretary may specify after consultation with the Federal Acquisition Regulatory Council, which shall apply with respect to all exceptions issued under paragraph (2). </text></clause></subparagraph></paragraph></subsection><subsection id="H8C925A3C5C23494BAABEC12A569EB54D"><enum>(b)</enum><header>Regulations</header><text>Not later than 18 months after the date of enactment of this Act, the Secretary, in consultation with the Federal Acquisition Regulatory Council, shall issue regulations to carry out subsection (a). </text></subsection><subsection id="HDA1649F9A747481B9E791BE90300E48E"><enum>(c)</enum><header>Definition</header><text>In this section, the term <term>consulting services</term>—</text><paragraph id="H192ABC32A7B24B7A8D52FB6D4BAB0F05"><enum>(1)</enum><text>means providing advice or recommendations to improve organizational effectiveness; and</text></paragraph><paragraph id="HB497C444057A4369A3301AA22C056276"><enum>(2)</enum><text>does not include services provided pursuant to a contract related to regulatory science research, public health surveillance, or information technology, or services provided by a small business concern.</text></paragraph></subsection></section></legis-body></bill> 

